Paul Knight
Stock Analyst at KeyBanc
(3.52)
# 2,299
Out of 4,707 analysts
264
Total ratings
44.6%
Success rate
4.7%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVTY Revvity | Maintained: Buy | $125 → $165 | $127.08 | +29.84% | 13 | Sep 4, 2026 | |
| LFCR Lifecore Biomedical | Maintained: Hold | n/a | $4.31 | - | 4 | Aug 6, 2026 | |
| TKNO Alpha Teknova | Maintained: Hold | n/a | $6.88 | - | 5 | Aug 6, 2026 | |
| WST West Pharmaceutical Services | Maintained: Buy | $350 → $390 | $337.75 | +15.47% | 16 | Jul 2, 2026 | |
| CSTL Castle Biosciences | Maintained: Buy | $50 → $35 | $32.76 | +6.84% | 9 | May 29, 2026 | |
| RPID Rapid Micro Biosystems | Maintained: Buy | $8 → $5 | $1.22 | +309.84% | 3 | May 29, 2026 | |
| CYRX Cryoport | Maintained: Buy | $15 → $17 | $15.47 | +9.89% | 10 | May 20, 2026 | |
| TECH Bio-Techne | Maintained: Hold | n/a | $72.31 | - | 19 | May 7, 2026 | |
| XGN Exagen | Maintained: Buy | $15 → $10 | $7.30 | +36.99% | 11 | Mar 11, 2026 | |
| STVN Stevanato Group | Rated: Buy | $37 → $32 | $20.32 | +57.48% | 7 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.692 | - | 9 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $220 | $168.53 | +30.54% | 13 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $310 | $205.23 | +51.05% | 9 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $750 | $603.02 | +24.37% | 9 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €415.00 → €320.00 | €238.10 | +34.40% | 2 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $35.38 | -6.73% | 10 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $220 | $124.34 | +76.93% | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | CHF 525.00 | CHF 389.60 | n/a | 1 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $146.85 | n/a | 12 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $460 | $402.91 | n/a | 9 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $30 | $15.25 | n/a | 3 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $7 → $30 | $7.95 | n/a | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $28.46 | n/a | 2 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $123.74 | n/a | 3 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 610.00 → CHF 635.00 | CHF 556.00 | n/a | 6 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $7.19 | n/a | 9 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $30.82 | n/a | 9 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $300 | $280.76 | n/a | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $250 | $259.21 | n/a | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.27 | n/a | 6 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $6.85 | n/a | 1 | Apr 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 → $30 | $17.56 | n/a | 3 | Feb 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $2 | $0.001 | n/a | 8 | Nov 26, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.05 | n/a | 2 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $42.45 | n/a | 7 | Nov 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $211.06 | n/a | 6 | Oct 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $58.37 | n/a | 4 | Mar 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.10 | n/a | 2 | Mar 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $50.31 | n/a | 1 | Feb 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $75 → $85 | $225.66 | n/a | 2 | Jul 24, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $2.26 | n/a | 1 | May 5, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $61 → $46 | $11.89 | n/a | 2 | Dec 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $255 | $1,325.52 | n/a | 1 | Aug 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $24 | $42.38 | n/a | 1 | Aug 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $18 | $0.35 | n/a | 1 | Aug 15, 2013 |
Revvity
Sep 4, 2026
Maintained: Buy
Price Target: $125 → $165
Current: $127.08
Upside: +29.84%
Lifecore Biomedical
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $4.31
Upside: -
Alpha Teknova
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $6.88
Upside: -
West Pharmaceutical Services
Jul 2, 2026
Maintained: Buy
Price Target: $350 → $390
Current: $337.75
Upside: +15.47%
Castle Biosciences
May 29, 2026
Maintained: Buy
Price Target: $50 → $35
Current: $32.76
Upside: +6.84%
Rapid Micro Biosystems
May 29, 2026
Maintained: Buy
Price Target: $8 → $5
Current: $1.22
Upside: +309.84%
Cryoport
May 20, 2026
Maintained: Buy
Price Target: $15 → $17
Current: $15.47
Upside: +9.89%
Bio-Techne
May 7, 2026
Maintained: Hold
Price Target: n/a
Current: $72.31
Upside: -
Exagen
Mar 11, 2026
Maintained: Buy
Price Target: $15 → $10
Current: $7.30
Upside: +36.99%
Stevanato Group
Mar 5, 2026
Rated: Buy
Price Target: $37 → $32
Current: $20.32
Upside: +57.48%
Feb 25, 2026
Maintained: Hold
Price Target: n/a
Current: $0.692
Upside: -
Feb 25, 2026
Maintained: Buy
Price Target: $220
Current: $168.53
Upside: +30.54%
Dec 18, 2025
Rated: Buy
Price Target: $310
Current: $205.23
Upside: +51.05%
Dec 8, 2025
Upgraded: Buy
Price Target: $750
Current: $603.02
Upside: +24.37%
Oct 7, 2025
Maintained: Buy
Price Target: €415.00 → €320.00
Current: €238.10
Upside: +34.40%
Oct 3, 2025
Maintained: Buy
Price Target: $33
Current: $35.38
Upside: -6.73%
Sep 10, 2025
Maintained: Buy
Price Target: $220
Current: $124.34
Upside: +76.93%
Sep 4, 2025
Initiated Coverage: Buy
Price Target: CHF 525.00
Current: CHF 389.60
Upside: n/a
Aug 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $146.85
Upside: n/a
Aug 18, 2025
Maintained: Buy
Price Target: $460
Current: $402.91
Upside: n/a
Jun 3, 2025
Reiterated: Buy
Price Target: $40 → $30
Current: $15.25
Upside: n/a
Apr 9, 2025
Downgraded: Hold
Price Target: $7 → $30
Current: $7.95
Upside: n/a
Mar 31, 2025
Downgraded: Hold
Price Target: n/a
Current: $28.46
Upside: n/a
Feb 5, 2025
Reiterated: Hold
Price Target: n/a
Current: $123.74
Upside: n/a
Jan 30, 2025
Maintained: Buy
Price Target: CHF 610.00 → CHF 635.00
Current: CHF 556.00
Upside: n/a
May 9, 2024
Rated: Hold
Price Target: n/a
Current: $7.19
Upside: n/a
Nov 14, 2023
Rated: Hold
Price Target: n/a
Current: $30.82
Upside: n/a
May 5, 2022
Maintained: Buy
Price Target: $300
Current: $280.76
Upside: n/a
Apr 28, 2022
Maintained: Buy
Price Target: $250
Current: $259.21
Upside: n/a
Mar 14, 2022
Downgraded: Hold
Price Target: n/a
Current: $4.27
Upside: n/a
Apr 15, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $6.85
Upside: n/a
Feb 27, 2020
Maintained: Hold
Price Target: $20 → $30
Current: $17.56
Upside: n/a
Nov 26, 2019
Downgraded: Hold
Price Target: $6 → $2
Current: $0.001
Upside: n/a
Jul 24, 2019
Downgraded: Hold
Price Target: n/a
Current: $5.05
Upside: n/a
Nov 29, 2018
Downgraded: Hold
Price Target: n/a
Current: $42.45
Upside: n/a
Oct 23, 2017
Upgraded: Hold
Price Target: n/a
Current: $211.06
Upside: n/a
Mar 27, 2017
Downgraded: Hold
Price Target: n/a
Current: $58.37
Upside: n/a
Mar 11, 2016
Downgraded: Hold
Price Target: n/a
Current: $1.10
Upside: n/a
Feb 10, 2016
Initiated Coverage: Buy
Price Target: n/a
Current: $50.31
Upside: n/a
Jul 24, 2014
Downgraded: Hold
Price Target: $75 → $85
Current: $225.66
Upside: n/a
May 5, 2014
Upgraded: Buy
Price Target: n/a
Current: $2.26
Upside: n/a
Dec 19, 2013
Rated: Hold
Price Target: $61 → $46
Current: $11.89
Upside: n/a
Aug 15, 2013
Initiated Coverage: Hold
Price Target: $255
Current: $1,325.52
Upside: n/a
Aug 15, 2013
Initiated Coverage: Hold
Price Target: $24
Current: $42.38
Upside: n/a
Aug 15, 2013
Initiated Coverage: Hold
Price Target: $18
Current: $0.35
Upside: n/a